Literature DB >> 10594785

Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria.

Y Hori1, K Yamada, N Hanafusa, T Okuda, N Okada, T Miyata, W G Couser, K Kurokawa, T Fujita, M Nangaku.   

Abstract

UNLABELLED: Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria.
BACKGROUND: Recent studies have suggested a role for urinary complement components in mediating tubulointerstitial damage, which is known to have a good correlation with progression of chronic renal diseases. Although accumulating evidence suggests that complement regulatory proteins play an important protective role in glomeruli, their role in renal tubules remains unclear. In order to establish the role of a complement regulatory protein, Crry, in renal tubular injury, we employed a molecular biological approach to block the expression of Crry in tubules of animals with proteinuria induced with puromycin aminonucleoside nephritis (PAN). Methods and Results. Two different antisense oligodeoxynucleotides (ODNs) against Crry were designed and applied to cultured rat mesangial cells in vitro in order to establish their efficacy. Antisense ODN treatment resulted in decreased expression of Crry protein associated with increased sensitivity to complement attack in cell lysis assays compared with control ODN treatment or no treatment (44.7, 1.50, and 1.34%, respectively). Antisense ODNs did not affect the expression of Thy1 as a control, confirming the specificity of our ODNs. In vivo, we performed selective right renal artery perfusion to administer antisense ODNs to the kidney and showed prominent uptake of ODNs by proximal tubular cells. Reduced expression of Crry protein was demonstrated in proximal tubular cells in antisense ODNs-treated kidneys. Normal rats treated with the antisense ODNs did not show any pathological changes. However, in PAN, rats with massive proteinuria showed increased deposition of C3 and C5b-9 in tubules in antisense-treated kidneys, and histological assessment revealed more severe tubulointerstitial injury in antisense-treated animals compared with controls.
CONCLUSION: These results establish a pathogenic role for complement in leading to tubulointerstitial injury during proteinuria and, to our knowledge for the first time, show a protective role of a complement regulatory protein, Crry, in renal interstitial disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594785     DOI: 10.1046/j.1523-1755.1999.00765.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Leaked protein and interstitial damage in the kidney: is complement the missing link?

Authors:  N S Sheerin; S H Sacks
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

2.  NF-κB signaling pathway-enhanced complement activation mediates renal injury in trichloroethylene-sensitized mice.

Authors:  Min Liu; Hui Wang; Jiaxiang Zhang; Xiaodong Yang; Bodong Li; Changhao Wu; Qixing Zhu
Journal:  J Immunotoxicol       Date:  2018-12       Impact factor: 3.000

Review 3.  A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

Authors:  Yashpal S Kanwar; Lin Sun; Ping Xie; Fu-You Liu; Sheldon Chen
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

4.  C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis.

Authors:  T R Welch; M Frenzke; D Witte; A E Davis
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

Review 5.  The role of innate immunity in donor organ procurement.

Authors:  Dianne B McKay
Journal:  Semin Immunopathol       Date:  2011-03-23       Impact factor: 9.623

6.  The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells.

Authors:  K Abe; K Li; S H Sacks; N S Sheerin
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

7.  Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.

Authors:  Jing Miao; Allison M Lesher; Takashi Miwa; Sayaka Sato; Damodar Gullipalli; Wen-Chao Song
Journal:  Kidney Int       Date:  2014-05-21       Impact factor: 10.612

8.  Glutathione inhibits antibody and complement-mediated immunologic cell injury via multiple mechanisms.

Authors:  Zhen Zhang; Xiling Zhang; Xin Fang; Manabu Niimi; Yanru Huang; Honglan Piao; Shan Gao; Jianglin Fan; Jian Yao
Journal:  Redox Biol       Date:  2017-03-31       Impact factor: 11.799

9.  The relative merits of therapies being developed to tackle inappropriate ('self'-directed) complement activation.

Authors:  Samuel Antwi-Baffour; Ransford Kyeremeh; Jonathan Kofi Adjei; Claudia Aryeh; George Kpentey
Journal:  Auto Immun Highlights       Date:  2016-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.